Your browser doesn't support javascript.
loading
Wholistic approach: Transcriptomic analysis and beyond using archival material for molecular diagnosis.
Macagno, Nicolas; Pissaloux, Daniel; de la Fouchardière, Arnaud; Karanian, Marie; Lantuejoul, Sylvie; Galateau Salle, Françoise; Meurgey, Alexandra; Chassagne-Clement, Catherine; Treilleux, Isabelle; Renard, Caroline; Roussel, Juliette; Gervasoni, Julie; Cockenpot, Vincent; Crozes, Carole; Baltres, Aline; Houlier, Aurélie; Paindavoine, Sandrine; Alberti, Laurent; Duc, Adeline; Le Loarer, Francois; Dufresne, Armelle; Brahmi, Mehdi; Corradini, Nadège; Blay, Jean-Yves; Tirode, Franck.
Afiliação
  • Macagno N; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Pissaloux D; Marmara Institute, INSERM, MMG, DOD-CET, Aix-Marseille University, Marseille, France.
  • de la Fouchardière A; NETSARC+, French Sarcoma Group (GSF-GETO) Network, France.
  • Karanian M; CARADERM, French Network of Rare Skin Cancers, France.
  • Lantuejoul S; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Galateau Salle F; INSERM 1052, CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France.
  • Meurgey A; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Chassagne-Clement C; INSERM 1052, CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France.
  • Treilleux I; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Renard C; NETSARC+, French Sarcoma Group (GSF-GETO) Network, France.
  • Roussel J; INSERM 1052, CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France.
  • Gervasoni J; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Cockenpot V; INSERM 1052, CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France.
  • Crozes C; Grenoble Alpes University, Grenoble, France.
  • Baltres A; MESOPATH, MESOBANK, French Network of Mesothelioma, France.
  • Houlier A; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Paindavoine S; MESOPATH, MESOBANK, French Network of Mesothelioma, France.
  • Alberti L; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Duc A; NETSARC+, French Sarcoma Group (GSF-GETO) Network, France.
  • Le Loarer F; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Dufresne A; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Brahmi M; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Corradini N; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Blay JY; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Tirode F; Department of Biopathology, Centre Léon Bérard, Lyon, France.
Genes Chromosomes Cancer ; 61(6): 382-393, 2022 06.
Article em En | MEDLINE | ID: mdl-35080790
Many neoplasms remain unclassified after histopathological examination, which requires further molecular analysis. To this regard, mesenchymal neoplasms are particularly challenging due to the combination of their rarity and the large number of subtypes, and many entities still lack robust diagnostic hallmarks. RNA transcriptomic profiles have proven to be a reliable basis for the classification of previously unclassified tumors and notably for mesenchymal neoplasms. Using exome-based RNA capture sequencing on more than 5000 samples of archival material (formalin-fixed, paraffin-embedded), the combination of expression profiles analyzes (including several clustering methods), fusion genes, and small nucleotide variations has been developed at the Centre Léon Bérard (CLB) in Lyon for the molecular diagnosis of challenging neoplasms and the discovery of new entities. The molecular basis of the technique, the protocol, and the bioinformatics algorithms used are described herein, as well as its advantages and limitations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transcriptoma / Neoplasias Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transcriptoma / Neoplasias Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article